MedUni Vienna    Accessibility    Contact    Intranet    Shop    Library    Vienna General Hospital (AKH)    

WELCOME to CeMSIIS’ research focus area „Re-USE of health data for medical research“.

Data are too expensive to waste
(Frank Harrell Jr., 2001)

By „Re-USE” we mean the utilization of data for other purposes than originally intended. We are restricting this definition to human data arising in a clinical or health care context, and their utilization to purposes of medical research.

On the following pages, information on background, vision and mission of the research focus area, methodology and current and past projects can be found.

The research focus area is supported by all Sections of CeMSIIS; a list of all members of its core group is available at the collaboration page.



12.5.2017: Datenschutz-Anpassungsgesetz 2018

[12.5.2017 Re-USE cr]

[: Austrian Parliament Logo :]The Austrian Data Protection Act is superseded by the EU General Data Protection Regulation in May 2018. Currently the new version of the Austrian Datenschutz-Anpassungsgesetz 2018 is evaluation in the Austrian Parliament. This act regulates beside other things how personalized data and medical data can be re-used for scientific purposes.

Datenschutz-Anpassungsgesetz 2018

Re-use of EHR data to estimate cases for trial recruitment

[7.7.2016 Re-USE cr]

[:Service from IT4Science:]

The EHR data in the data warehouse (RDA) at the Medical University Vienna is re-used to estimate the cases complying with feasibility criteria for trial recruitment. In contrast to similar approaches proposed in the IMI project EHR4CR and the InSitePlatform the query is not triggered remotely using structured inclusion criteria. Enquiries are sent by e-mail and the service is just available for employees of the Medical University Vienna.

Further details about the Service: IT4Science Service

Talk: How well does the Framingham Prediction Model predict the Cardiovascular Risk of Austrians?

[2.6.2016 Re-USE cr]

[:YSA PhD Symposium 2016:] Austria’s health screening program (AHSP) is designed to improve prevention of various diseases including cardiovascular disease (CVD) - a leading cause of death and disability. The Framingham CVD model is a popular CVD risk prediction tool, but used an American study cohort. Christine Wallisch will present her work on prediction models for cardiovascular risk at the YSA PhD Symposium 2016 on the 9th and 10th of June in Lecture Hall 3 (Floor 7 AKH)

Further details about the YSA PhD Symposium: YSA PhD Symposium

FEATURED PUBLICATION: Improving the informational continuity of care in diabetes mellitus treatment

[31.5.2016 Re-USE cr]

[: IJMI caluclation of index visit :]The goal of this study was to quantitatively analyze (i) the degree of fragmentation of diabetis mellitus care in Austria as an indicator for the need for health information exchange, and (ii) the quantity of information (i.e. number of documents) from Austrian diabetes mellitus patients that would be made available by a nationwide Shared EHR system for health information exchange. Health claims data from the Main Association of the Austrian Social Security Institutions was re-used.

The full publication can be seen here: